Deciphering the pathogenic role of a variant with uncertain significance for short QT and Brugada syndromes using gene‐edited human‐induced pluripotent stem cell‐derived cardiomyocytes and preclinical drug screening

Detalles Bibliográficos
Autores principales: El‐Battrawy, Ibrahim, Lan, Huan, Cyganek, Lukas, Maywald, Lasse, Zhong, Rujia, Zhang, Feng, Xu, Qiang, Lee, Jihyun, Duperrex, Eliane, Hierlemann, Andreas, Saguner, Ardan M., Duru, Firat, Kovacs, Boldizsar, Huang, Mengying, Liao, Zhenxing, Albers, Sebastian, Müller, Jonas, Dinkel, Hendrik, Rose, Lena, Hohn, Alyssa, Yang, Zhen, Qiao, Lin, Li, Yingrui, Lang, Siegfried, Kleinsorge, Mandy, Mügge, Andreas, Aweimer, Assem, Fan, Xuehui, Diecke, Sebastian, Akin, Ibrahim, Li, Guang, Zhou, Xiaobo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Letter to Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710296/
https://www.ncbi.nlm.nih.gov/pubmed/34954893
http://dx.doi.org/10.1002/ctm2.646

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710296/
https://www.ncbi.nlm.nih.gov/pubmed/34954893
http://dx.doi.org/10.1002/ctm2.646

Ejemplares similares